Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo Berruti

Showing results (101-110 of 380) with videos related to

Pageof 38
Sort By:
The Prostate|May 10, 2013
Human ASH-1 promotes neuroendocrine differentiation in androgen deprivation conditions and interferes with androgen responsiveness in prostate cancer cellsIda Rapa, Marco Volante, Cristina Migliore, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|May 1, 2010
Diagnostic accuracy and complication rate of CT-guided fine needle aspiration biopsy of lung lesions: a study based on the experience of the cytopathologistAdriano Massimiliano Priola, Sandro Massimo Priola, Aldo Cataldi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2020
Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation TherapiesAlberto Dalla Volta, Gherardo Mazziotti, Filippo Maffezzoni, et al.
Plos One|May 8, 2018
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cellsAntonina Germano, Laura Saba, Silvia De Francia, et al.
Expert Opinion on Emerging Drugs|September 4, 2008
Emerging drugs for adrenocortical carcinomaAlfredo Berruti, Anna Ferrero, Paola Sperone, et al.
Endocrine|January 5, 2021
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in ItalyDeborah Cosentini, Salvatore Grisanti, Marta Laganà, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panelAlfredo Berruti, Martin Fassnacht, Eric Baudin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Could the efficacy of docetaxel in prostate cancer patients be potentiated by concomitant high-dose calcitriol administration?Alfredo Berruti, Marcello Tucci, Alessandra Mosca, et al.
Cancers|December 23, 2022
Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: A Systematic Review and Meta-AnalysisMaria Gemelli, Diego Luigi Cortinovis, Alice Baggi, et al.
Cancer Treatment Reviews|April 16, 2013
Strategies for managing ACTH dependent mineralocorticoid excess induced by abirateroneAnna Pia, Francesca Vignani, Gerhardt Attard, et al.
Pageof 38

Showing results (101-110 of 380) with videos related to

Sort By:
Pageof 38
The Prostate|May 10, 2013
Human ASH-1 promotes neuroendocrine differentiation in androgen deprivation conditions and interferes with androgen responsiveness in prostate cancer cellsIda Rapa, Marco Volante, Cristina Migliore, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|May 1, 2010
Diagnostic accuracy and complication rate of CT-guided fine needle aspiration biopsy of lung lesions: a study based on the experience of the cytopathologistAdriano Massimiliano Priola, Sandro Massimo Priola, Aldo Cataldi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2020
Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation TherapiesAlberto Dalla Volta, Gherardo Mazziotti, Filippo Maffezzoni, et al.
Plos One|May 8, 2018
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cellsAntonina Germano, Laura Saba, Silvia De Francia, et al.
Expert Opinion on Emerging Drugs|September 4, 2008
Emerging drugs for adrenocortical carcinomaAlfredo Berruti, Anna Ferrero, Paola Sperone, et al.
Endocrine|January 5, 2021
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in ItalyDeborah Cosentini, Salvatore Grisanti, Marta Laganà, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panelAlfredo Berruti, Martin Fassnacht, Eric Baudin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Could the efficacy of docetaxel in prostate cancer patients be potentiated by concomitant high-dose calcitriol administration?Alfredo Berruti, Marcello Tucci, Alessandra Mosca, et al.
Cancers|December 23, 2022
Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: A Systematic Review and Meta-AnalysisMaria Gemelli, Diego Luigi Cortinovis, Alice Baggi, et al.
Cancer Treatment Reviews|April 16, 2013
Strategies for managing ACTH dependent mineralocorticoid excess induced by abirateroneAnna Pia, Francesca Vignani, Gerhardt Attard, et al.
Pageof 38